FI811101L - Isoxazolylindolaminer - Google Patents

Isoxazolylindolaminer

Info

Publication number
FI811101L
FI811101L FI811101A FI811101A FI811101L FI 811101 L FI811101 L FI 811101L FI 811101 A FI811101 A FI 811101A FI 811101 A FI811101 A FI 811101A FI 811101 L FI811101 L FI 811101L
Authority
FI
Finland
Prior art keywords
isoxazolylindolaminer
Prior art date
Application number
FI811101A
Other languages
English (en)
Other versions
FI69843B (fi
FI69843C (fi
Inventor
Leonard Jay Brand
Jeffrey Nadelson
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI811101L publication Critical patent/FI811101L/fi
Publication of FI69843B publication Critical patent/FI69843B/fi
Application granted granted Critical
Publication of FI69843C publication Critical patent/FI69843C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI811101A 1980-04-10 1981-04-09 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara isoxazolylindolaminer FI69843C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US13887380A 1980-04-10 1980-04-10
US13887280A 1980-04-10 1980-04-10
US13887280 1980-04-10
US13887380 1980-04-10
US19678580A 1980-10-14 1980-10-14
US19678580 1980-10-14

Publications (3)

Publication Number Publication Date
FI811101L true FI811101L (fi) 1981-10-11
FI69843B FI69843B (fi) 1985-12-31
FI69843C FI69843C (fi) 1986-05-26

Family

ID=27385244

Family Applications (1)

Application Number Title Priority Date Filing Date
FI811101A FI69843C (fi) 1980-04-10 1981-04-09 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara isoxazolylindolaminer

Country Status (11)

Country Link
EP (2) EP0038298B1 (fi)
AU (1) AU546620B2 (fi)
CA (1) CA1163267A (fi)
DE (1) DE3164982D1 (fi)
DK (1) DK153881A (fi)
ES (1) ES8300757A1 (fi)
FI (1) FI69843C (fi)
IL (1) IL62605A (fi)
MY (1) MY8500913A (fi)
NZ (1) NZ196762A (fi)
PT (1) PT72817B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE11770T1 (de) * 1981-12-14 1985-02-15 Sandoz-Erfindungen Verwaltungsgesellschaft M.B.H. N,n,disubstituierte alkenamide und phenylaldenamide, verfahren zu deren herstellung und deren verwendung als pharmazeutika.
CH656124A5 (de) * 1982-04-13 1986-06-13 Sandoz Ag 2-substituierte-3-indolamine, verfahren zu deren herstellung sowie deren verwendung.
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
MC2210A1 (fr) * 1990-06-07 1992-11-26 Wellcome Found Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1075156A (en) * 1963-08-27 1967-07-12 Luso Farmaco Inst Substituted piperazines
US3467670A (en) * 1964-10-05 1969-09-16 Mcneilab Inc 2-phenyl-3-amido-5,6-dimethoxyindoles
US4059583A (en) * 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles

Also Published As

Publication number Publication date
ES501220A0 (es) 1982-11-01
DE3164982D1 (de) 1984-08-30
MY8500913A (en) 1985-12-31
EP0038298A1 (en) 1981-10-21
EP0083566A1 (en) 1983-07-13
PT72817B (en) 1982-07-26
IL62605A (en) 1984-10-31
AU6930181A (en) 1981-10-15
ES8300757A1 (es) 1982-11-01
IL62605A0 (en) 1981-06-29
NZ196762A (en) 1984-07-06
PT72817A (en) 1981-05-01
CA1163267A (en) 1984-03-06
AU546620B2 (en) 1985-09-12
EP0038298B1 (en) 1984-07-25
DK153881A (da) 1981-10-11
FI69843B (fi) 1985-12-31
FI69843C (fi) 1986-05-26

Similar Documents

Publication Publication Date Title
BE887534A (fr) Sandwichpaneelelement
BE889577A (nl) Golfvormsynthese
BE891422A (fr) Degrilleur
BR8107326A (pt) Container-tanque
BR8101718A (pt) Microcentrais
BE889192A (fr) Recolteuse-hacheuse
BE889004A (nl) Grijper
BR8108640A (pt) Filatorio
DE3163961D1 (de) Heteroalkylene-bis-anthraquinones
BR8108621A (pt) Arpeu
BE889708A (fr) Sous-soleuse
FI811101L (fi) Isoxazolylindolaminer
BE890439A (fr) Afdekbaanrol
BE890703A (fr) Robinet-vanne
BE891654A (fr) Schuifdeur
BE887835A (fr) Fluidumsysteem
BE888818A (fr) Telerupteur
JPS5736798A (ja) Hodentotentosochi
AR219450A1 (es) Portasachet
BE891105A (nl) Kontinupers
BR6000208U (pt) Molicar
BR8001657A (pt) Oxigenador
BR8000436A (pt) Amalgamador
BR8007025A (pt) Vagonete monotrilho
BR8006091A (pt) Momicroencapsulacao

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG